BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11690653)

  • 1. Delineation of the minimal catalytic domain of human Galbeta1-3GalNAc alpha2,3-sialyltransferase (hST3Gal I).
    Vallejo-Ruiz V; Haque R; Mir AM; Schwientek T; Mandel U; Cacan R; Delannoy P; Harduin-Lepers A
    Biochim Biophys Acta; 2001 Oct; 1549(2):161-73. PubMed ID: 11690653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and expression of cDNA for a human Gal(beta1-3)GalNAc alpha2,3-sialyltransferase from the CEM T-cell line.
    Giordanengo V; Bannwarth S; Laffont C; Van Miegem V; Harduin-Lepers A; Delannoy P; Lefebvre JC
    Eur J Biochem; 1997 Jul; 247(2):558-66. PubMed ID: 9266697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
    Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
    Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of galactose alpha2,3-sialyltransferase: Ciona intestinalis ST3GAL I/II and Takifugu rubripes ST3GAL II sialylate Galbeta1,3GalNAc structures on glycoproteins but not glycolipids.
    Lehmann F; Kelm S; Dietz F; von Itzstein M; Tiralongo J
    Glycoconj J; 2008 May; 25(4):323-34. PubMed ID: 17973185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of evolutionarily conserved glycosylation at Asn211 in the intracellular trafficking and activity of sialyltransferase ST3Gal-II.
    Ruggiero FM; Vilcaes AA; Iglesias-Bartolomé R; Daniotti JL
    Biochem J; 2015 Jul; 469(1):83-95. PubMed ID: 25916169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning and expression of Galbeta1,3GalNAc alpha2, 3-sialyltransferase from human fetal liver.
    Shang J; Qiu R; Wang J; Liu J; Zhou R; Ding H; Yang S; Zhang S; Jin C
    Eur J Biochem; 1999 Oct; 265(2):580-8. PubMed ID: 10504389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-cell-specific transcriptional regulation of human Galbeta1,3GalNAc/Galbeta1,4GlcNAc alpha2,3-sialyltransferase (hST3Gal IV) gene.
    Taniguchi A; Matsumoto K
    Biochem Biophys Res Commun; 1999 Apr; 257(2):516-22. PubMed ID: 10198243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression.
    Kono M; Ohyama Y; Lee YC; Hamamoto T; Kojima N; Tsuji S
    Glycobiology; 1997 Jun; 7(4):469-79. PubMed ID: 9184827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and expression of human Gal beta 1,3GalNAc alpha 2,3-sialytransferase (hST3Gal II).
    Kim YJ; Kim KS; Kim SH; Kim CH; Ko JH; Choe IS; Tsuji S; Lee YC
    Biochem Biophys Res Commun; 1996 Nov; 228(2):324-7. PubMed ID: 8920913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The signal anchor and stem regions of the beta-galactoside alpha 2,6-sialyltransferase may each act to localize the enzyme to the Golgi apparatus.
    Colley KJ; Lee EU; Paulson JC
    J Biol Chem; 1992 Apr; 267(11):7784-93. PubMed ID: 1560012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hexapeptide inhibitor of Galbeta 1,3GalNAc-specific alpha 2,3-sialyltransferase as a generic inhibitor of sialyltransferases.
    Lee KY; Kim HG; Hwang MR; Chae JI; Yang JM; Lee YC; Choo YK; Lee YI; Lee SS; Do SI
    J Biol Chem; 2002 Dec; 277(51):49341-51. PubMed ID: 12379642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
    Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J
    J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Location and mechanism of alpha 2,6-sialyltransferase dimer formation. Role of cysteine residues in enzyme dimerization, localization, activity, and processing.
    Qian R; Chen C; Colley KJ
    J Biol Chem; 2001 Aug; 276(31):28641-9. PubMed ID: 11356854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.
    Martin LT; Marth JD; Varki A; Varki NM
    J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical localization of alpha2,3(N)-sialyltransferase (ST3Gal III) in cell lines and rat kidney tissue sections: evidence for golgi and post-golgi localization.
    Burger PC; Lötscher M; Streiff M; Kleene R; Kaissling B; Berger EG
    Glycobiology; 1998 Mar; 8(3):245-57. PubMed ID: 9451034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
    Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis for enzyme activity of mouse Galbeta1,3GalNAc alpha2,3-sialyltransferase (mST3Gal I).
    Kim KS; Oh SU; Lee JH; Lee YC
    Indian J Biochem Biophys; 2010 Jun; 47(3):135-40. PubMed ID: 20653283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids.
    Okajima T; Fukumoto S; Miyazaki H; Ishida H; Kiso M; Furukawa K; Urano T; Furukawa K
    J Biol Chem; 1999 Apr; 274(17):11479-86. PubMed ID: 10206952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two naturally occurring alpha2,6-sialyltransferase forms with a single amino acid change in the catalytic domain differ in their catalytic activity and proteolytic processing.
    Ma J; Qian R; Rausa FM; Colley KJ
    J Biol Chem; 1997 Jan; 272(1):672-9. PubMed ID: 8995311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and enzymatic characterization of CMP-sialic acid: beta-galactosyl1----3-N-acetylgalactosaminide alpha 2----3-sialyltransferase from human placenta.
    Joziasse DH; Bergh ML; ter Hart HG; Koppen PL; Hooghwinkel GJ; Van den Eijnden DH
    J Biol Chem; 1985 Apr; 260(8):4941-51. PubMed ID: 3988739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.